Sharfstein Pledges FDA Spending Will Generate Public Health Value
Executive Summary
The FDA under Margaret Hamburg and Joshua Sharfstein will be a proactive, results-oriented public health agency, Sharfstein indicated to congressional appropriations panels May 21
You may also be interested in...
Rx Safety: FDA Needs Deadline - Not Funding - To Improve Process, GAO Says
GAO is not buying an FDA assertion that the delay in giving the Office of Surveillance and Epidemiology more responsibility for post-market drug safety decisions is a funding issue
Horowitz Goes From FDA Office Of Policy To HHS Office Of General Counsel
The departure of FDA Assistant Commissioner for Policy David Horowitz to become a deputy general counsel at the Department of Health and Human Service's Office of General Counsel gives Commissioner Margaret Hamburg the opportunity to further shape the agency's senior staff
Rx Safety: FDA Needs Deadline - Not Funding - To Improve Process, GAO Says
GAO is not buying an FDA assertion that the delay in giving the Office of Surveillance and Epidemiology more responsibility for post-market drug safety decisions is a funding issue